- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 154
BrainQ secures $40m in funding round
Dexcel Pharma joins second funding round for BrainQ’s artificial intelligence (AI)-based technology.
Aug 17, 2021Zupee wraps up $30m series B round
Smile Group returns to invest in Zupee’s platform, which lets users compete for real money via trivia games.
Aug 17, 2021Chime hits $25bn valuation in $750m round
SoftBank helped the digital financial services provider raise a series G round led by Sequoia Capital, reaching a post-money valuation of $25bn.
Aug 17, 2021SoftBank helps serve Gelato with $240m
SoftBank Vision Fund 2 was among the investors in the tailor-made item platform operator’s latest round, which took its valuation past the $1bn threshold.
Aug 17, 2021Ualá banks $350m series D at $2.45bn valuation
Softbank and Tencent backed the digital banking app provider in a series D round which will be use to boost its expansion in Argentina and Mexico, develop new products and scale up its team.
Aug 17, 2021Rapido rushes to $52m series C
Bike taxi service provider Rapido has surpassed $130m of overall funding through a series C round featuring corporate investors Shell Ventures, Yamaha and Positive Moves Consulting.
Aug 17, 2021Hireup finds fresh funding
Seek Investments has provided $29.5m for the disability support worker matching platform, having also formed a strategic alliance with the business.
Aug 17, 2021Daily deal net: August 17, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Aug 17, 2021GentiBio jumps to $157m series A
Matrix Capital Management led the immunology drug developer's series A round, which will support the journey of a type 1 diabetes drug candidate towards the clinic.
Aug 17, 2021GentiBio jumps to $157m series A
Novartis Venture Fund returned as GentiBio raised money that will support the progress of its type 1 diabetes drug candidate toward clinical trials.
Aug 17, 2021About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


